Answers are grounded in this paper and cite their sources.
The source of human factor VIIII (FVIII) had a marked effect on the inhibitory activity of a panel of eight human FVIII inhibitors. Use of conventional FVIII concentrates gave lower inhibitor titres whereas a monoclonal antibody purified FVIII concentrate gave titres similar to or greater than those with plasma. Addition of phospholipid (PL) protected highly purified FVIII against inhibition. The content of PL-bound FVIII in concentrates may account for the observed differences.
No takes yet. Share an insight, caveat, or question.
Littlewood et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: